miR-148a-3p suppresses epithelial ovarian cancer progression primarily by targeting c-Met

被引:73
|
作者
Wang, Wen [1 ,2 ]
Dong, Jing [1 ]
Wang, Maoxiu [1 ]
Yao, Shujuan [1 ]
Tian, Xiangyu [3 ]
Cui, Xiujuan [1 ]
Fu, Shijie [4 ]
Zhang, Shiqian [2 ]
机构
[1] Jining Med Univ, Affiliated Tengzhou Cent Peoples Hosp, Dept Obstet & Gynecol, Tengzhou 277599, Shandong, Peoples R China
[2] Shandong Univ, Qilu Hosp, Dept Obstet & Gynecol, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China
[3] Jining Med Univ, Dept Med Imaging, Affiliated Tengzhou Cent Peoples Hosp, Tengzhou 277599, Shandong, Peoples R China
[4] Anhui Med Univ, Dept Clin Med, Hefei 230032, Anhui, Peoples R China
关键词
microRNA-148a-3p; c-Met; epithelial ovarian cancer; malignancy; tyrosine protein kinase Met; PHASE-I UNIT; MESENCHYMAL TRANSITION; UVEAL MELANOMA; EXPRESSION; BIOMARKER; CELLS; ABERRATIONS; METASTASES; INVASION; RECEPTOR;
D O I
10.3892/ol.2018.8110
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MicroRNAs (miRNAs) are a group of small non-coding RNAs that modulate post-transcriptional gene expression. It has been demonstrated that various miRNAs may be expressed at different levels in different types of tumors. The present study assessed the role of microRNA-148a-3p (miR-148a-3p) in epithelial ovarian cancer (EOC). The results demonstrated that miR-148a-3p was decreased in EOC tissues and that a lower miRa-148-3p concentration was associated with a higher overall survival rate. Transfection of miR-148a-3p suppressed the invasive and proliferative capacity of SKOV3 cells. The induced overexpression of miR-148a-3p significantly inhibited the relative luciferase activity of the pmirGLO-c-Met-3' untranslated region compared with an empty vector. In addition, c-Met silencing led to a decrease in the invasive and proliferative capacity of EOC cells. The inhibition of miR-148a-3p did not increase the invasiveness of SKOV3 cells, even when c-Met was silenced. To the best of our knowledge, the present study is the first to demonstrate that miR-148a-3p expression is decreased in EOC cancer tissues and cell lines. The present study therefore demonstrated that miR-148a-3p may serve as a tumor suppressor in EOC by targeting c-Met.
引用
收藏
页码:6131 / 6136
页数:6
相关论文
共 50 条
  • [1] MiR-148a-3p suppresses the progression of gastric cancer cells through targeting ATP6AP2
    Jin, Xiaosheng
    Cai, Peipei
    Shi, Zhengchao
    Ye, Fangpeng
    Ji, Tingting
    Li, Rongzhou
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2020, 19 (09) : 1821 - 1826
  • [2] RETRACTED: Long non-coding RNA SNHG4 promotes cervical cancer progression through regulating c-Met via targeting miR-148a-3p (Retracted article. See MAY, 2023)
    Li, Hanchen
    Hong, Jiang
    Wijayakulathilaka, Walimuni Sandaroo Mendis Abeysekara
    CELL CYCLE, 2019, 18 (23) : 3313 - 3324
  • [3] miR-148a-3p promotes rabbit preadipocyte differentiation by targeting PTEN
    He, Hongbing
    Cai, Mingcheng
    Zhu, Jiaoyue
    Xiao, Wudian
    Liu, Buwei
    Shi, Yu
    Yang, Xue
    Liang, Xiaohu
    Zheng, Tianhao
    Hu, Shenqiang
    Jia, Xianbo
    Chen, Shiyi
    Wang, Jie
    Qin, Yinghe
    Lai, Songjia
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2018, 54 (03) : 241 - 249
  • [4] miR-148a-3p inhibits alpaca melanocyte pigmentation by targeting MITF
    Zhu, Zhiwei
    Cai, Yongqiang
    Li, Yuan
    Li, Huifeng
    Zhang, Lihuan
    Xu, Dongmei
    Yu, Xiuju
    Li, Pengfei
    Lv, Lihua
    SMALL RUMINANT RESEARCH, 2019, 177 : 44 - 49
  • [5] MiR-539-3p promotes the progression of epithelial ovarian cancer by targeting SPARCL1
    Gong, Y-B
    Fan, X-H
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (06) : 2366 - 2373
  • [6] miR-148a-3p suppresses the progression of acute myeloid leukemia via targeting cyclin-dependent kinase 6 (CDK6)
    Zhou, Hong
    Jia, Xiaofeng
    Yang, Fan
    Shi, Pengfei
    BIOENGINEERED, 2021, 12 (01) : 4508 - 4519
  • [7] MiR-23b-3p suppresses epithelial-mesenchymal transition, migration, and invasion of hepatocellular carcinoma cells by targeting c-MET
    Park, Na Ri
    Cha, Jung Hoon
    Sung, Pil Soo
    Jang, Jeong Won
    Choi, Jong Young
    Yoon, Seung Kew
    Bae, Si Hyun
    HELIYON, 2022, 8 (10)
  • [8] Promoter methylation-regulated miR-148a-3p inhibits lung adenocarcinoma (LUAD) progression by targeting MAP3K9
    Liang, Lu
    Xu, Wen-yan
    Shen, Ao
    Cen, Hui-yu
    Chen, Zhi-jun
    Tan, Lin
    Zhang, Ling-min
    Zhang, Yu
    Fu, Ji-jun
    Qin, Ai-ping
    Lei, Xue-ping
    Li, Song-pei
    Qin, Yu-yan
    Huang, Jiong-hua
    Yu, Xi-yong
    ACTA PHARMACOLOGICA SINICA, 2022, 43 (11) : 2946 - 2955
  • [9] MicroRNA-101 suppresses motility of bladder cancer cells by targeting c-Met
    Hu, Zhenghui
    Lin, Yiwei
    Chen, Hong
    Mao, Yeqing
    Wu, Jian
    Zhu, Yi
    Xu, Xin
    Xu, Xianglai
    Li, Shiqi
    Zheng, Xiangyi
    Xie, Liping
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 435 (01) : 82 - 87
  • [10] miR-542-3p suppresses colorectal cancer progression through targeting survivin
    Ye, Chunxiang
    Yue, Guanjun
    Shen, Zhanlong
    Wang, Bo
    Yang, Yang
    Li, Tao
    Mao, Shuqiang
    Jiang, Kewei
    Ye, Yingjiang
    Wang, Shan
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 (06) : 817 - 826